cs.AIMar 23, 2026

Cerebra: A Multidisciplinary AI Board for Multimodal Dementia Characterization and Risk Assessment

Authors: Sheng Liu, Long Chen, Zeyun Zhao, Qinglin Gou, Qingyue Wei, Arjun Masurkar, Kevin M. Spiegler, Philip Kuball, +11 more

Organizations: Department of Biomedical Data Science, Stanford University · Department of Radiation Oncology, Stanford University · Center for Data Science, New York University · J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida · Department of Biomedical Engineering and Informatics, Indiana University Indianapolis · Department of Neurology, NYU Grossman School of Medicine · Department of Neuroscience, NYU Grossman School of Medicine · UF Health Family Medicine – Haile Plantation · Department of Family Medicine, Indiana University School of Medicine · Department of Biostatistics and Health Data Science, Indiana University School of Medicine · Center for Biomedical Informatics, Regenstrief Institute · Scripps Research Translational Institute · Courant Institute, New York University · Center for Cognitive Aging and Memory, McKnight Brain Institute, University of Florida · Population Health Department, NYU Langone Health · Radiology Department, NYU Langone Health

Abstract

Modern clinical practice increasingly depends on reasoning over heterogeneous, evolving, and incomplete patient data. Although recent advances in multimodal foundation models have improved performance on various clinical tasks, most existing models remain static, opaque, and poorly aligned with real-world clinical workflows. We present Cerebra, an interactive multi-agent AI team that coordinates specialized agents for EHR, clinical notes, and medical imaging analysis. These outputs are synthesized into a clinician-facing dashboard that combines visual analytics with a conversational interface, enabling clinicians to interrogate predictions and contextualize risk at the point of care. Cerebra supports privacy-preserving deployment by operating on structured representations and remains robust when modalities are incomplete. We evaluated Cerebra using a massive multi-institutional dataset spanning 3 million patients from four independent healthcare systems. Cerebra consistently outperformed both state-of-the-art single-modality models and large multimodal language model baselines. In dementia risk prediction, it achieved AUROCs up to 0.80, compared with 0.74 for the strongest single-modality model and 0.68 for language model baselines. For dementia diagnosis, it achieved an AUROC of 0.86, and for survival prediction, a C-index of 0.81. In a reader study with experienced physicians, Cerebra significantly improved expert performance, increasing accuracy by 17.5 percentage points in prospective dementia risk estimation. These results demonstrate Cerebra's potential for interpretable, robust decision support in clinical care.

Figures & tables

Appendix figures & tables13 assets

Supplementary material from the paper’s appendix.

Appendix

Explore similar work

Jun 19, 2026

Dementia-Agents: A Multi-Modal Multi-Agent System for Dementia Staging and Phenotyping

Dementia diagnosis requires integrating multi-modal clinical assessments from diverse informants and clinicians under incomplete and heterogeneous data conditions. Yet most AI-driven approaches remain Alzheimer's disease (AD)-centric, framing the problem as binary AD detection or three-stage AD progression modeling within well-curated research settings. This pathology-driven paradigm overlooks the broader, syndrome-level nature of dementia, which spans multiple stages, phenotypes, and etiologies. In this paper, we propose Dementia-Agents, a clinically aligned multi-agent framework for real-world dementia staging and phenotyping. The framework follows a three-step workflow: (1) a data agent translates structured clinical records into semantically faithful textual representations that preserve missing-data signals and routes them to domain-aligned experts; (2) five fine-tuned expert agents generate domain-level predictions; and (3) a coordinator agent performs probabilistic aggregation to produce final staging and phenotyping decisions. We develop and evaluate Dementia-Agents on a real-world clinical cohort of 1,066 patients from two cognitive neurology services. Compared with monolithic multi-modal large language models (MLLMs) and prior medical multi-agent systems, our approach achieves consistent improvements in diagnostic performance for real-world syndrome-level dementia staging and phenotyping, while preserving domain-level interpretability.
Jul 24, 2026

Dementia Etiology Diagnosis via Collaborative Meta Knowledge Enhancement

Although artificial intelligence (AI) has shown promising performance in several medical tasks, accurate dementia etiology diagnosis with AI remains challenging due to complex overlapping symptoms among diseases. Scaling up the dataset size by combining the cross-center samples may bring a gain in the pursuit of performance, while the inherent data heterogeneity across centers or populations induces the conflict. Conventional multi-task learning paradigms offer a promising framework; however, they fail to consider critical meta information (e.g., site-specific acquisition and modality availability) to combat the heterogeneity. To address this challenge, we propose a Collaborative Meta Knowledge Enhancement (COME) framework for dementia etiology diagnosis, which injects multi-center acquisition semantics, source identifiers, and modality indicators as heterogeneity-aware embeddings into a unified Transformer architecture for scale-up training, enabling explicit modeling of heterogeneity. Besides, a trust-region constrained optimization scheme is designed to regularize the model from spurious correlations during training through a reference model. Across seven independent cohorts, our method achieves state-of-the-art in-domain performance with a mean macro-averaged AUC of 85.62% and a 4.29-point gain over the strongest baseline, while maintaining superior out-of-domain generalization under both cross-center and cross-sequence evaluations. Extensive validation also confirms the alignment between model predictions and established biomarkers (amyloid, tau) and clinical severity, highlighting the potential of COME to enable robust and interpretable dementia diagnostics in real-world settings.
May 11, 2026

AgentRx: A Benchmark Study of LLM Agents for Multimodal Clinical Prediction Tasks

Building effective clinical decision support systems requires the synthesis of complex heterogeneous multimodal data. Such modalities include temporal electronic health records data, medical images, radiology reports, and clinical notes. Large language model (LLM)-based agents have shown impressive performance in various healthcare tasks, especially those involving textual modalities. Considering the fragmentation of healthcare data across hospital systems, collaborative agent frameworks present a promising direction to mitigate data sharing challenges. However, the effectiveness of LLM agents for multimodal clinical risk prediction remains largely unexamined. In this work, we conduct a systematic evaluation of LLM-based agents for clinical prediction tasks using large-scale real-world data. We assess performance in unimodal and multimodal settings and quantify performance gaps between single agent and multi-agent systems. Our findings highlight that single agent frameworks outperform naive multi-agent systems, are better at handling multimodal data, and are better calibrated. This underscores a critical need for improving multi-agent collaboration to better handle heterogeneous inputs. By open-sourcing our code and evaluation framework, this work offers a new benchmark to support future developments relating to agentic systems in healthcare.